Showing 1 - 7 results of 7 for search 'Hinrich Abken', query time: 0.02s Refine Results
  1. 1
    Weal and woe of interleukin-18 in the T cell therapy of cancer

    Weal and woe of interleukin-18 in the T cell therapy of cancer by Christoph Kessel, Hinrich Abken, Claudia Rossig

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells

    Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells by Claudia Schlimper, Andreas A. Hombach, Hinrich Abken, Ingo G. H. Schmidt-Wolf

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion

    Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion by Dennis Christoph Harrer, Tim Schlierkamp-Voosen, Markus Barden, Hong Pan, Maria Xydia, Wolfgang Herr, Jan Dörrie, Niels Schaft, Hinrich Abken

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Anti-CD19 CAR T cells potently redirected to kill solid tumor cells.

    Anti-CD19 CAR T cells potently redirected to kill solid tumor cells. by Christine Ambrose, Lihe Su, Lan Wu, Fay J Dufort, Thomas Sanford, Alyssa Birt, Benjamin J Hackel, Andreas Hombach, Hinrich Abken, Roy R Lobb, Paul D Rennert

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Zelig Eshhar (1941–2025): a tribute for a life for immunotherapy

    Zelig Eshhar (1941–2025): a tribute for a life for immunotherapy by Carl H June, Steven A Rosenberg, Crystal Mackall, Michel Sadelain, James P Allison, Eric Smith, Michael T Lotze, Marcela V Maus, Hinrich Abken, Renier Brentjens, Robbie G Majzner

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation

    CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation by Michael Hudecek, Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, Deborah Sandfort, Julia Lahrberg, Stephan Klöß, Christina Kloth, Caroline Mangare, Agnes Bonifacius, Sabine Tischer-Zimmermann, Rainer Blasczyk, Britta Maecker-Kolhoff, Barbara Uchanska-Ziegler, Hinrich Abken, Axel Schambach, Britta Eiz-Vesper

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma

    Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma by Krasimira Aleksandrova, Jana Leise, Christoph Priesner, Murat Aktas, Michael Apel, Mario Assenmacher, Iris Bürger, Anne Richter, Pia Altefrohne, Christine Schubert, Astrid Holzinger, Markus Barden, Valerie Bezler, Michael von Bergwelt-Baildon, Peter Borchmann, Lilia Goudeva, Wolfgang Glienke, Lubomir Arseniev, Ruth Esser, Hinrich Abken, Ulrike Koehl, Ulrike Koehl, Ulrike Koehl

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: